Wikidata

(Q64679433)

English

A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.

clinical trial

In more languages

Statements

short name
CHEST-1 (English)
0 references
title
Randomized, Double-blind, Placebo-controlled, Multi-centre, Multi-national Study to Evaluate the Efficacy and Safety of Oral BAY63-2521 (1 mg, 1.5 mg, 2 mg, or 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Canada
0 references
Czech Republic
0 references
Denmark
0 references
France
0 references
Germany
0 references
Republic of Ireland
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Mexico
0 references
Netherlands
0 references
Poland
0 references
Portugal
0 references
Slovakia
0 references
Spain
0 references
Switzerland
0 references
Taiwan
0 references
Turkey
0 references
United Kingdom
0 references
start time
February 2009
0 references
end time
June 2012
0 references
number of participants
262
0 references
minimum age
18 year
0 references
maximum age
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64679433&oldid=1857941689"